Lingling Han

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 850 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparison of the two up-to-date sequencing technologies for genome assembly: HiFi reads of Pacific Biosciences Sequel II system and ultralong reads of Oxford Nanopore

Dandan Lang, Shilai Zhang, Pingping Ren et al. · GigaScience · 2020 · 175 citations · Full text

Life Sciences, Biotechnology, Genetics +14

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection

Gregory T. Everson, William Towner, Mitchell Davis et al. · Annals of Internal Medicine · 2015 · 112 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection

Stephen Pianko, Steven L. Flamm, Mitchell L. Shiffman et al. · Annals of Internal Medicine · 2015 · 97 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

Jason Grebely, Gregory J. Dore, Stefan Zeuzem et al. · Clinical Infectious Diseases · 2016 · 92 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +12